Cargando…
Radioprotective effects of roxadustat (FG‐4592) in haematopoietic system
BACKGROUND: Ionizing radiation often causes severe injuries to radiosensitive tissues, especially haematopoietic system. Novel radioprotective drugs with low toxicity and high effectiveness are required. Prolyl hydroxylases domain (PHD) inhibitors have been reported to protect against radiation‐indu...
Autores principales: | Zhang, Pei, Du, Jicong, Zhao, Hainan, Cheng, Ying, Dong, Suhe, Yang, Yanyong, Li, Bailong, Gao, Fu, Sun, Xuejun, Cai, Jianming, Liu, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307774/ https://www.ncbi.nlm.nih.gov/pubmed/30334352 http://dx.doi.org/10.1111/jcmm.13937 |
Ejemplares similares
-
The mechanism for the radioprotective effects of zymosan‐A in mice
por: Du, Jicong, et al.
Publicado: (2018) -
Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients
por: Ding, Kai, et al.
Publicado: (2023) -
FG-4592 protects the intestine from irradiation-induced injury by targeting the TLR4 signaling pathway
por: Feng, Zhenlan, et al.
Publicado: (2022) -
Roxadustat (FG-4592) Facilitates Recovery From Renal Damage by Ameliorating Mitochondrial Dysfunction Induced by Folic Acid
por: Li, Xue, et al.
Publicado: (2022) -
Antianemia Drug Roxadustat (FG-4592) Protects Against Doxorubicin-Induced Cardiotoxicity by Targeting Antiapoptotic and Antioxidative Pathways
por: Long, Guangfeng, et al.
Publicado: (2020)